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The introduction of spectral domain optical coherence tomography (SD-OCT) has enhanced Vitreoretinal Interface (VRI)
imaging considerably and facilitated the diagnosis, followup, prognosis determination, and management of VRI-associated
pathologies. HR-OCT became a common practical tool seen in almost every ophthalmology practice. Knowledge of SD-OCT
image interpretation and recognition of pathologies are required for all ophthalmologists. This paper methodically reviews
the normal aging process of the VRI and discusses several commonly encountered VRI pathologies. The role of SD-OCT
imaginginVRI-associateddisorderssuchasposteriorvitreousdetachment,vitreomaculartractionsyndrome,idiopathicepiretinal
membranes, lamellar holes, pseudoholes, and full thickness macular holes is portrayed. Future perspectives of new OCT
technologies based on SD-OCT are discussed.
1.The VitreoretinalInterface
The vitreoretinal interface (VRI) is a complex composite
structure connecting the vitreous cortex and the inner retina
as illustrated in Figure 1.
The posterior vitreous cortex is 100µm thick. It consists
of densely packed collagen ﬁbrils [1] that insert superﬁcially
into the internal limiting membrane (ILM) of the retina [2]
and attach to the ILM by glue-like macromolecules, such
as laminin, ﬁbronectin, chondroitin, and heparan sulphate
proteoglycans [3]. The strongest vitreoretinal adhesions have
been described at the optic disc, over the retinal blood
vesselsandatthemaculararea[3].Thisintimaterelationship
between cortical vitreous and the retina triggers many of the
frequently encountered macular pathologies.
Aging of the human vitreous is characterized by gel
liquefaction and the development of ﬂuid-ﬁlled pockets,
typically beginning in front of the macula and in the
central vitreous cavity [4] This progressive process may
begin as early as the second decade and eventually leads
to degeneration of the vitreous gel and weakened vitreo-
retinal adhesion. As the collagen-hyaluronate complexes
composing the vitreous progressively degenerate, liqueﬁed
vitreous pockets enlarge and enter the posterior hyaloid
space. Collapse of the vitreous gel, known as syneresis, leads
to a complete PVD with time [2].
Optical coherence tomography (OCT), introduced in
the 1990’s, is a noninvasive in vivo ophthalmic imaging
technique [5]. OCT is based on the principal of Michelson
interferometry [6]. Interference patterns produced by low
coherence light reﬂected from ocular tissues are processed
into an “A-scan” signal. Multiple A-scan signals are aligned
to produce a “B-scan” two-dimensional image that can
be thought of as a form of “in vivo histology [6].” In
2002, the time-domain OCT, which was based on a moving
reference mirror, became commercially available with an
axial resolution of 10µm.
Since2004,higherresolutionspectral-domainOCT(SD-
OCT) has entered clinical ophthalmic practice. SD-OCT is
not limited by moving parts. SD-OCT relies on a spectrom-
eter and high-speed camera using the mathematical premise
of Fourier transformation for analysis of the reﬂected light.
This results in a signiﬁcant increase in the amount of data2 Journal of Ophthalmology
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Figure 1: Illustration of the vitreoretinal attachments at the vitreoretinal interface. The posterior vitreous cortex is attached to the ILM by
collagen ﬁbers at the vitreoretinal interface. These ﬁbers fuse with the ILM and along with macromolecules, such as laminin, ﬁbronectin,
and chondroitin anchor the vitreous cortex to the retina.
acquired during each session while reducing motion artifacts
with an increased signal-to-noise ratio when compared
with time-domain OCT. Commercial available SD-OCT
machines have a reported axial resolution of 5 to 7 microns
[7]. There are some prototypes achieving 3 microns of axial
resolution [7].
This cross-sectional imaging technology has allowed
investigators to study and manage patients with VRI
disease processes that were previously unrecognizable by
biomicroscopy alone. OCT was the primary contributor to
our understanding of the pathogenesis and the anatomical
sequence of events that underlie VRI pathologies. This
revolutionary imaging modality is now prevalent in all
ophthalmology clinic settings as it greatly enhances physi-
cians’ ability to recognize and diagnose VRI pathologies.
This paper reviews the uses of SD-OCT in the evaluation,
followup, and management of VRI-associated disorders such
as posterior vitreous detachment, vitreomacular traction
syndrome, idiopathic epiretinal membranes, lamellar holes,
pseudoholes, and full thickness macular holes as illustrated
in Figure 2.
2. Posterior VitreousDetachment
Posterior vitreous detachment (PVD) is deﬁned as a separa-
tionbetweentheposteriorvitreouscortexandtheILMofthe
retina (Figure 3).
Aging of the vitreous and syneresis leads to a complete
P V Dw i t ht i m e[ 2]. The most commonly associated clinical
symptom is the development of ﬂoaters. With aging, com-
plete PVD becomes more common with a 10% prevalence in
people under the age of 50 and up to 63% of people over the
age of 70 [8]. The most common complications of PVD are
retinal tears, vitreous hemorrhage, rhegmatogenous retinal
detachment, and retinal or optic disc hemorrhage [2, 6, 9].
These complications are mainly caused by dynamic vitreous
traction on focal areas of ﬁrm vitreoretinal adhesion [9].
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Figure 2: Vitreoretinal-interface-associated pathologies.
Figure 3: Posterior vitreous detachment (arrow).
For many years PVD could only be diagnosed clinically
using biomicroscopy and was believed to be an acute event.
Subsequently,ultrasonographywasusedasthemainimaging
modalityfordocumentationofPVD[2].Despiteitsrelatively
gross resolution (1mm) it is nonetheless a reliable tool
to determine the presence of a PVD [10]. It is indeed
advantageous in eyes with media opacities such as corneal
opacities, dense cataracts, vitreous hemorrhage, or vitreous
inﬂammation.Journal of Ophthalmology 3
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Figure 4: SD-OCT images of PVD and vitreoschisis. PVD; posterior hyaloid (arrow) separated from the retina (a). Vitreoschisis with
liquefaction (double-head arrow) of the vitreous between a formed vitreous (asterisk) and an attached posterior hyaloid (arrow).
SD-OCT enables us, in our day-to-day practice, to image
and to study the posterior hyaloid face and its intimate
relationshipwiththeretina. Itallowsnotonlyearlydiagnosis
of vitreous pathologies but also the ability to diﬀerentiate
PVD from other clinical entities, such as vitreoschisis
(Figure 4). The SD-OCT is a reliable and an objective tool
to assist the clinician in making the correct diagnosis and
determining treatment options. For example, an observation
of vitreomacular traction syndrome following an acute
traumatic incomplete PVD that was recently demonstrated
by SD-OCT may be transient in nature, allowing the option
of observation and followup by SD-OCT as an alternative to
early surgical intervention [11]. A recent study by Johnson
[4] used SD-OCT imaging to evaluate the early stages of
PVD.It was revealedthat PVD is most probablyan insidious,
chronic event that begins in the perifoveal macula and
progressively detaches over a prolonged period of time,
leavingthefovealandopticnerveattachmenttoseparatelast.
The majority of PVDs are asymptomatic and do not
require any treatment [4]. Most symptomatic patients expe-
rience ﬂoaters and predominantly do well with observation
alone.Althoughstillcontroversial,therehavebeenagrowing
numberofrecentreportsadvocatingsmallincisionsutureless
vitrectomy surgery for the removal of symptomatic ﬂoaters
[12, 13].
VitreoschisisandincompletePVD,determinedinpartby
the size and strength of the residual vitreoretinal adhesion
[4], may be complicated by a variety of vitreoretinal interface
pathologies in the macular area as discussed below.
3. Vitreomacular TractionSyndrome
TheclassicformofVitreomaculartraction(VMT)syndrome
is characterized by partial PVD with residual strong and
focal posterior vitreomacular adhesions. This results in
anteroposterior and tangential tractional forces applied by
the vitreous to the foveal and parafoveal regions. Based
on SD-OCT data, it appears that there are 2 subclasses of
vitreomacular traction; focal foveolar adhesion and broad
macular adhesion [4, 14, 15]. Decreased visual acuity may
result from secondary intraretinal edema and a distortion of
the normal macular architecture. Other common symptoms
associated with VMT syndrome include metamorphopsia,
micropsia, and photopsia.
Figure 5: Vitreomacular traction.
Now commercially available, OCT has been tremen-
dously helpful in conﬁrming many cases of VMT that were
clinically undetectable (Figure 5). Although conventional
time domain OCT was able to demonstrate the vitreoretinal
interface, the ability to image the posterior hyaloid mem-
brane was limited by the slow scan speed, limited sensitivity,
and poor axial resolution. The increased axial resolution, the
augmentedsignal/noiseratio,andthehigherscanrateofnew
SD-OCT have dramatically improved the ability to visualize
the vitreomacular interface and posterior hyaloid membrane
[16].
Three-dimensional scans made possible with SD-OCT
have advanced the comprehensive evaluation of the vitre-
oretinal interface providing additional clinically signiﬁcant
information. The 3-dimensional reconstruction modality
enables meticulous presurgical planning, with the potential
for improved postsurgical outcomes [16]. Koizum et al. [14]
performed a three-dimensional evaluation of the VRI in
VMT syndrome using SD-OCT. They found that most of the
eyes with VMT syndrome had concurrent epiretinal mem-
branes. These epiretinal membranes increase the adhesion
between the vitreous and the retina and serve as an anchor
for the cortical vitreous on the inner surface of the retina
therefore preventing spontaneous separation of the vitreous
from the macula.
SD-OCT has triggered focused attention to special
conditions in which VRI pathologies develop. For instance,
a complete PVD is less prevalent in diabetic patients with
clinically signiﬁcant diabetic macular edema compared to
diabetic patients without diabetic macular edema [17]. It
is well established that diabetic macular edema may be
exacerbated by the vitreomacular traction eﬀects of partial
vitreous detachment [18]. A recent study using SD-OCT to
assesstheVRIineyeswithdiabeticmacularedema,epiretinal4 Journal of Ophthalmology
membranes, and incomplete PVD [19] found that the
posterior cortical vitreous and the hyper-reﬂective adherent
membrane, which is generally designated as an epiretinal
membrane, appeared as one continuous thick membrane.
Based on these novel observations which were supported
by histologic ﬁndings [20], it can be assumed that the
hyperreﬂectiveadherentepimacularmembraneiscommonly
composed of an integrated ﬁbrocellular membrane from the
epiretinal membraneposterior hyaloid complex.
In daily practice, in addition to conﬁrming the diagnosis
of VMT, SD-OCT plays an important role in following
patients with VMT and in determining their visual prog-
nosis. In some cases, spontaneous resolution of traction
may occur, justifying a period of clinical observation before
surgical intervention [21, 22]. For symptomatic patients,
small gauge vitrectomy surgery and release of the vitreous
traction may be easily and safely applied [23, 24]. It is
importanttokeepinmindthatclinicalandhistologicstudies
haveshownthatresidualcorticalvitreouscommonlyadheres
to the inner retinal surface following vitrectomy despite
peeling of the posterior hyaloids [25]. Cortical postoperative
vitreousremnantsmayorganizeintoaﬁbrocellularepiretinal
membrane with subsequent contraction causing macular
pucker [26]. Other limitations of vitrectomy include surgical
complications such as retinal tears, retinal detachments,
cataract formation/progression, and intraocular infection as
well as high costs.
Pharmacologic vitreolysis, applied as an intravitreal
injection, is an emerging possible treatment for persistent
vitreomacular-adhesion-related pathologies [27].
Over the past 15 years, investigators have increasingly
examined alternative methods for PVD induction which
focused on the use of pharmacologic agents to modify the
molecular structure of the vitreous thereby eliminating its
role in the pathogenesis of retinal diseases. While early
interest in pharmacologic vitreolysis has focused on its
application as an adjunct to vitrectomy surgery and removal
of ﬁbrovascular proliferative membranes [28], investigators
have quickly realized its potential as a stand-alone therapy
[29]. Vitreolytic agents may potentially improve anatomical
and functional outcomes in VMT patients. They may also be
used as a prophylactic measure in conditions in which PVD
is associated with an improved prognosis (DME) [27].
Results from an initial clinical trial evaluating the safety
and preliminary eﬃcacy of vitreolysis with intravitreal
microplasmin in patients suﬀering from VMT show the drug
to be well tolerated and capable of inducing a pharmacologic
P V Di ns o m ep a t i e n t s[ 30].
The ancillary beneﬁts of pharmacologic vitreolysis
include: decreased costs, based on shorter surgical times or
decreased incidence of progressive disease requiring surgery;
greater access to therapy, based on the simple instrumenta-
tion involved in the injection administration and a possible
future transition to oﬃce-based procedures [31]. Further-
more, these agents will reduce patient exposure to inherent
vitrectomy-related complications, such as endophthalmitis,
cataract formation, iatrogenic retinal breaks and anesthesia
related complications [27].
Figure 6: Full thickness macular hole.
4. FullThickness Macular Hole
Full thickness macular hole (FTMH) is a vertical split in the
foveal neurosensory retina (Figure 6). It is more common in
females and occurs primarily in the sixth to eighth decades
of life. The risk of developing a macular hole in the other eye
of patients with unilateral macular hole has been reported
to be 11–13% overall [32]; however, it increases to 50% if a
premacular hole conﬁguration is noted on OCT [33].
The etiology of macular hole formation is still unknown.
SD-OCT data gathered in recent years support the hypoth-
esis that vitreoretinal abnormalities and vitreomacular trac-
tion play a major role in idiopathic macular hole formation
[32, 34]. Visual symptoms include metamorphopsia and
diminished central visual acuity ranging from 20/40 to 5/200
in later stages.
Clinically, a FTMH might be confused with other VRI
disorders such as a pseudohole and lamellar hole (discussed
below). SD-OCT helps the clinician distinguish between
these VRI conditions and has improved our understanding
of the role of vitreoretinal adhesions in the pathogenesis of
these disorders. The conventional management of FTMH is
surgical treatment. Initially advocated in 1991 by Kelly and
Wendel [35], vitrectomy with gas tamponade and face down
positioning is currently the treatment of choice for FTMH.
Variations of this procedure have evolved over the years to
include ILM peeling, with or without adjuvant staining [36].
Recent data questions the need for face down positioning
a f t e rs u r g e r yf o rs m a l l( <400µm) FTMH [37, 38]. More
recently, pharmacological vitreolysis has been recommended
for the closure of small FTMH [30].
In day to day retina clinic, SD-OCT is an invaluable
tool in the pre- and postoperative diagnosis and followup
of patients with FTMH. Newly, a mathematical analog of
the premacular hole foveal anatomic conﬁguration was ﬁrst
described to enable recognition of patients prone to devel-
oping FTMH (as seen in Figure 7)[ 33]. Using OCT foveal
thickness maps, the mathematical analog of a premacular
hole, foveal anatomic conﬁguration was found to be signif-
icantly diﬀerent from the normal foveal conﬁguration and
was composed of a steep nonsymmetrical foveal slope with a
wide fovea on OCT scans. Fifty percent of the patients with
a premacular hole conﬁguration consequently developed
bilateral macular holes. This high incidence compared to a
previously reported incidence of 11% to 13% of bilateral
macular holes [32] may indicate that this foveal conﬁgura-
tion predisposes a subset of high risk patients to develop
bilateral macular holes [33]. The exciting new clinical ability
to identify this distinct macular conﬁguration may allowJournal of Ophthalmology 5
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Figure 7: Premacular hole conﬁguration SD-OCT (right) and foveal thickness graph (left) illustrating steep and asymmetrical slopes.
Figure 8: Lamellar hole with intact photoreceptors.
Figure 9: Pseudohole without any neurosensory defects.
early diagnosis, close followup and better management of
macular hole-prone patients as seen in Figure 7 [33].
SD-OCT is also used to determine the prognosis for
vision recovery by assessing the structural integrity of the
photoreceptors before and after macular hole surgery by
imaging of the inner segment/outer segment photoreceptor
(IS/OS junction) defect in patients with macular holes. The
extent of the IS/OS junction defect can be a prognostic
feature for the visual outcome after macular hole surgery
[39, 40]. A study evaluating the ability of SD-OCT images of
the IS/OS junction to predict macular hole surgery outcomes
demonstrated that the mean total area and maximum length
of the IS/OS junction defect at 12 months after surgery was
signiﬁcantly and negatively correlated with the postoperative
visual acuity. The conclusion of the study was that SD-OCT
is useful for quantitatively measuring IS/OS junction defects,
andthatpostoperativeIS/OSjunctionmayplayanimportant
role in visual recovery after macular hole surgery [40].
5.LamellarHole
Lamellarholeisapartialthicknessdefectintheneurosensory
retina with intact photoreceptors, as shown in (Figure 8).
6. Pseudohole
Pseudohole is a hole in an epiretinal membrane (ERM)
without any neurosensory defects in the retina (Figure 9).
Figure 10: Epiretinal membrane (arrow).
7.EpiretinalMembrane
Epiretinal membrane (ERM) or macular pucker is an
avascular, ﬁbrocellular membrane on the inner surface of the
retina (Figure 10).
ERM results from proliferative changes at the VRI and
can be either secondary to other ocular conditions or
idiopathic in nature. Secondary membranes are associated
with a variety of retinal disorders, including retinal tears,
retinal vascular diseases (branch retinal vein occlusion and
central retinal vein occlusion), uveitis, trauma, or retinal
detachment surgery [1]. Partial or complete PVD has been
found in 80% to 95% of eyes with idiopathic ERM [41]. This
wassuggestedtobesecondarytovitreousschisisandvitreous
remnants on the retina promoting subsequent epiretinal
ﬁbrocellular proliferation [42].
Idiopathic premacular membranes have a wide range of
severity. They may be quite subtle, causing minimal loss of
vision or may result in macular edema and distorted vision
caused by traction exerted by the membrane and resultant
leakage from the perifoveal capillaries.
In clinical practice SD-OCT has proven useful in the
evaluation and treatment of ERMs. Using SD-OCT, one
can easily diﬀerentiate the posterior hyaloid, a minimally
reﬂectivesignal,fromanERM,whichishighlyreﬂective[43].
OCT has also been helpful in conﬁrming the relationship
between PVD and ERM. OCT is valuable for following
the natural history of epiretinal membranes [43]. Visually
signiﬁcant ERMs are usually removed surgically resulting in
a 2-line improvement on average [44]. Although surgical
intervention was previously advised only after signiﬁcant
reduction in visual acuity (<20/60), SD-OCT made it
possible to obtain a very accurate image of early changes
in the retina, such as ERM-related macular edema and/or
distortion of the inner and outer retina allowing early,
minimally invasive, small gauge surgical intervention, and
possibly better visual outcome.6 Journal of Ophthalmology
8.FuturePerspective
New advancements in the use of high-resolution OCT for
retinal imaging are continuously emerging. These practical
and experimental tools most probably will have a marked
impact on the way we treat our patients in retina practice
in the future. One of the most intriguing developments is
the experimental use of intraoperative microscope-mounted
SD-OCT. The possibility to use SD-OCT intraoperatively
provides thrilling new insights into the subtle changes of
retinal anatomy during the performance of macular surgery.
Intra-operative SD-OCT may be a future practical tool for
facilitating vitreoretinal surgery [45]. SD-OCT high axial
resolution also allows for a three dimensional en face or “C-
scan” to be produced oﬀering a new view of the diﬀerent
layers of the retina and the vitreoretinal relationship [7, 46].
Another new development is the Swept source OCT that can
achieve ultrahigh axial resolution of 2-3µm by sweeping a
narrowbandwidthlightsourcethroughabroadopticalrange
[47]. Total retinal blood ﬂow measurement with this newer
ultrahigh speed swept source/Fourier domain OCT [47]m a y
enable us to demonstrate and measure the increased blood
ﬂow reported after peeling of the posterior hyaloid [48]a n d
may abele us to measure blood ﬂow in occlusive retinal
vascular diseases and/or ischemic diseases of the retina.
9. Conclusion
SD-OCT has broadened a new horizon in the basic
understanding and interpretation of vitreoretinal interface
disorders.Itallowsearlydiagnosis,betterfollowup,andmore
intelligent information-based surgical decision making. SD-
OCT has recently been used in the screening of patients
at risk for vitreoretinal interface disorders, as well as
determining and predicting their visual prognosis. With
further advancement of this technology, higher resolution
OCT carries the potential of perfecting visual outcomes for
patients with VRI disorders.
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